Manufacturer record
Nixi Laboratories Pvt.Ltd VPO. Mouza Ogli: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Nixi Laboratories Pvt.Ltd VPO. Mouza Ogli (Himachal Pradesh) was declared Not of Standard Quality in October 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: L25DU002, Vecuronium Bromide Injection IP 10 mg (exp Jan 2027). CDL, Kolkata (CDSCO lab) found it not of standard quality: The sample does not conform to I.P. with respect to the Test for Water Content and Assay of Vecuronium Bromide. Listed in the October 2025 alert.
Records by type
1 record linked to Nixi Laboratories Pvt.Ltd VPO. Mouza Ogli in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Vecuronium Bromide Injection IP 10 mg | Batch L25DU002Mfg Feb 2025 · Exp Jan 2027 | The sample does not conform to I.P. with respect to the Test for Water Content and Assay of Vecuronium BromideAssay | CDL, KolkataCDSCO lab | Oct 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.